Group One Trading
SMMT icon

Group One Trading’s Summit Therapeutics SMMT Stock Holding History

Group One Trading’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$648K Buy
44,450
+1,669
+4% +$29.6K ﹤0.01% 3250
2026
Q1 		$811K Buy
42,781
+11,371
+36% +$184K ﹤0.01% 2907
2025
Q4 		$549K Buy
31,410
+1,160
+4% +$21.8K ﹤0.01% 3412
2025
Q3 		$625K Buy
+30,250
New +$734K ﹤0.01% 3463
2025
Q1 		– Sell
-223,418
Closed -$4.48M – 8322
2024
Q4 		$3.99M Buy
223,418
+36,500
+20% +$708K 0.01% 1326
2024
Q3 		$4.09M Buy
+186,918
New +$2.61M 0.01% 1153
2024
Q2 		– Sell
-30,019
Closed -$162K – 7429
2024
Q1 		$124K Buy
+30,019
New +$119K ﹤0.01% 3963
2023
Q4 		– Sell
-33,074
Closed -$68K – 8146
2023
Q3 		$61.8K Sell
33,074
-183,376
-85% -$350K ﹤0.01% 4886
2023
Q2 		$543K Buy
216,450
+75,787
+54% +$138K ﹤0.01% 2929
2023
Q1 		$246K Buy
140,663
+137,666
+4,593% +$375K ﹤0.01% 3471
2022
Q4 		$12.7K Sell
2,997
-21,717
-88% -$39.5K ﹤0.01% 5898
2022
Q3 		$29K Buy
+24,714
New +$28K ﹤0.01% 5836
2021
Q3 		– Sell
-100
Closed -$718 – 8743
2021
Q2 		$1K Buy
+100
New +$656 ﹤0.01% 8031
2020
Q4 		– Sell
-400
Closed -$1K – 6960
2020
Q3 		$1K Hold
400
– – ﹤0.01% 5955
2020
Q2 		$1K Buy
+400
New +$1.38K ﹤0.01% 5671
2020
Q1 		– Sell
-700
Closed -$1K – 5707
2019
Q4 		$1K Hold
700
– – ﹤0.01% 4991
2019
Q3 		$1K Hold
700
– – ﹤0.01% 5006
2019
Q2 		$1K Hold
700
– – ﹤0.01% 4831
2019
Q1 		$1K Hold
700
– – ﹤0.01% 4670
2018
Q4 		$1K Buy
+700
New +$1.09K ﹤0.01% 4746

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Group One Trading's SMMT Position: Q2 2026 in Review

Group One Trading increased its Summit Therapeutics (SMMT) stake by 3.9% in Q2 2026, buying an estimated $29.6K and bringing the position to 44,450 shares worth $648K. The position accounts for ﹤0.01% of the portfolio, ranked #3250.

Group One Trading first reported a position in SMMT in Q4 2018 and has held it in 20 quarters since. The position peaked at $4.09M in Q3 2024. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • Group One Trading held 44,450 shares of Summit Therapeutics worth $648K as of Q2 2026.
  • Group One Trading bought 1,669 Summit Therapeutics shares in Q2 2026, an estimated $29.6K.
  • Summit Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #3250 holding.
  • Group One Trading first reported a position in Summit Therapeutics in Q4 2018 and has held it in 20 quarters since.
  • Group One Trading's Summit Therapeutics position peaked at $4.09M in Q3 2024.
  • 242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.